(Q82907190)

English

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis

scientific article published on 13 December 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

relapsing-remitting multiple sclerosis

1 reference

based on heuristic

inferred from title

Olivier Outteryck

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nicolas Collongues

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

A Melin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M C Fleury

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Lacour

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J C Ongagna

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A S Berteloot

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P Vermersch

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

13 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

259

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1215-1221

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22160375%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three years of experience: the Italian registry and safety data update.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Swedish natalizumab (Tysabri) multiple sclerosis surveillance study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22160375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82907190&oldid=2221304374"